Umaima Ahmad

Non-Executive Director

Following a career as a senior finance lawyer for global institutions including Citibank, Umaima continued practising law in the life sciences at Abcam before moving into business development at AstraZeneca, where she negotiates significant licensing and divestment transactions across multiple therapy areas.

Umaima is co-founder and Chief Business Officer of 52 North Health, a board member of the UK Pharmaceutical Licensing Group and a trustee of Cambridge Community Arts.

She is a graduate of King’s College London, the University of Strasbourg and BPP Law School and holds an MPhil in Bioscience Enterprise from the University of Cambridge.

Keep up to date with all HEE news and events.

We take your data very seriously, please read our privacy policy.

Talk to us

We offer a free 30-minute consultation to explore how our team of experts can help you develop, commercialise and scale your medical technology.

Book Now